FDA authorizes second COVID booster for Americans over age 50

FDA authorizes second COVID booster for Americans over age 50

CBS 2

Published

The authorization for a second COVID booster came from the FDA on Tuesday. It comes as the CDC estimates the Omicron subvariant BA.2 is now the dominant strain in new cases; CBS2's Christina Fan reports.

Full Article